Paper41121981
Phenotypic, Genotypic Characteristics, and Treatment Strategies of Pediatric Tyrosine Hydroxylase Deficiency: A Single-Center Retrospective Analysis of 51 Cases.
Ban T and 9 others. Mov Disord Clin Pract, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Phenotypic, Genotypic Characteristics, and Treatment Strategies of Pediatric Tyrosine Hydroxylase Deficiency: A Single-Center Retrospective Analysis of 51 Cases. Papers, record 41121981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41121981
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Phenotypic, Genotypic Characteristics, and Treatment Strategies of Pediatric Tyrosine Hydroxylase Deficiency: A Single-Center Retrospective Analysis of 51 Cases.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Levodopa | Major topic |
| Tyrosine 3-Monooxygenase | Major topic |
| Dystonic Disorders | Major topic |
| Humans | |
| Male | |
| Female | |
| Retrospective Studies | |
| Child | |
| Child, Preschool | |
| Phenotype | |
| Genotype | |
| Adolescent | |
| Infant | |
| China |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40590098 | Early Levodopa Therapy in Tyrosine Hydroxylase Deficiency. | Mov Disord Clin Pract | 2025 | https://conductscience.org/library/papers/40590098 | PubMed |
| 2 | 20430833 | Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. | Brain | 2010 | https://conductscience.org/library/papers/20430833 | PubMed |
| 3 | 17696123 | Mutations in the cyclic adenosine monophosphate response element of the tyrosine hydroxylase gene. | Ann Neurol | 2007 | https://conductscience.org/library/papers/17696123 | PubMed |
| 4 | 34908184 | Relationship of Genotype, Phenotype, and Treatment in Dopa-Responsive Dystonia: MDSGene Review. | Mov Disord | 2022 | https://conductscience.org/library/papers/34908184 | PubMed |
| 5 | 32872068 | Dopa-responsive dystonia caused by tyrosine hydroxylase deficiency: Three cases report and literature review. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/32872068 | PubMed |
| 6 | 37160866 | In situ continuous Dopa supply by responsive artificial enzyme for the treatment of Parkinson's disease. | Nat Commun | 2023 | https://conductscience.org/library/papers/37160866 | PubMed |
| 7 | 36568392 | Segawa syndrome caused by TH gene mutation and its mechanism. | Front Genet | 2022 | https://conductscience.org/library/papers/36568392 | PubMed |
| 8 | 34834538 | Personalized Medicine to Improve Treatment of Dopa-Responsive Dystonia-A Focus on Tyrosine Hydroxylase Deficiency. | J Pers Med | 2021 | https://conductscience.org/library/papers/34834538 | PubMed |
| 9 | 38196161 | Tetrahydrobiopterin (BH4) treatment stabilizes tyrosine hydroxylase: Rescue of tyrosine hydroxylase deficiency phenotypes in human neurons and in a knock-in mouse model. | J Inherit Metab Dis | 2024 | https://conductscience.org/library/papers/38196161 | PubMed |
| 10 | 35164471 | R233H mutation in patients with tyrosine hydroxylase deficiency and corresponding phenotypes: a study of four cases and literature review. | J Integr Neurosci | 2022 | https://conductscience.org/library/papers/35164471 | PubMed |
| 11 | 32185155 | Clinical and Genetic Heterogeneity in a Cohort of Chinese Children With Dopa-Responsive Dystonia. | Front Pediatr | 2020 | https://conductscience.org/library/papers/32185155 | PubMed |
| 12 | 21496606 | Dopa-responsive dystonia. | Handb Clin Neurol | 2011 | https://conductscience.org/library/papers/21496606 | PubMed |
| 13 | 40113792 | Structural recognition and stabilization of tyrosine hydroxylase by the J-domain protein DNAJC12. | Nat Commun | 2025 | https://conductscience.org/library/papers/40113792 | PubMed |
| 14 | 34054692 | Identification of TH Variants in Chinese Dopa-Responsive Dystonia Patients and Long-Term Outcomes. | Front Neurol | 2021 | https://conductscience.org/library/papers/34054692 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42973816 | Tyrosine Hydroxylase Deficiency: From Clinical and Therapeutic Features to Pathogenetic Considerations. | Juntendo Med J | 2026 | https://conductscience.org/library/papers/42973816 | PubMed |
| 42941842 | Three Cases of Levodopa-Carbidopa Responsive Nocturnal Akinesis in Male Children of an Inbred Family in Rural Baluchistan, Pakistan. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941842 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41121981
GET https://conductscience.org/api/papers/v1/41121981/authors